First AD

Second AD

Sande Okelo, MD, leads a discussion on the updates in the GINA 2021 report regarding difficult-to-treat and severe asthma.

GINA Guidelines and Biologics for Treatment of Asthma

Asthma

The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Allergies, Asthma Exacerbations and Uncontrolled Asthma Management

Sande Okelo, MD, leads a discussion on the updates in the GINA 2021 report regarding difficult-to-treat and severe asthma, as well as considerations for GINA Step 4 and 5 treatment approaches.

External Factors and Seasonality of Asthma

Endotypes and Phenotypes in Asthma

Type 2 Inflammation and Biomarkers in Asthma

Moderate/Severe/Uncontrolled Asthma Classification

Thinking About Endotypes when Managing Asthma

Use of Oral Corticosteroids in Asthma

High Oral Corticosteroid Dose and Exposure in Asthma

Oral Corticosteroid Overuse and Uncontrolled Asthma

Biomarkers and Eosinophil Levels in Severe or Uncontrolled Asthma

Biologics in Asthma

Use of Biologics for Asthma in Patients with Allergies

Treatment of Asthma in Pediatric Patients

Atopic March in Pediatric Patients

Use of Biologics in Pediatric Patients and Conversations with Parents

Biologic Options in Pediatric Asthma

Advice for Clinicians Managing Asthma